India vs Big Pharma: Compulsory licence for leukaemia drug sought
Glaxo patent on breast cancer drug revoked
'Compulsory licence verdict a triumph for humanity'
Experts believe that this case will set a precedent for all future legal tangles between Big Pharma and the country as a marker of how cases pertaining to drug patents will be played out in the country.
Novartis not optimistic about Supreme Court verdict
Leading lawyer calls India's pharma sector 'hip and hapenning'
India vs Big Pharma: Compulsory licence for leukaemia drug sought
Glaxo patent on breast cancer drug revoked
'Compulsory licence verdict a triumph for humanity'
Experts believe that this case will set a precedent for all future legal tangles between Big Pharma and the country as a marker of how cases pertaining to drug patents will be played out in the country.
Novartis not optimistic about Supreme Court verdict
Leading lawyer calls India's pharma sector 'hip and hapenning'
